Nurix Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $476.8M
Liabilities Breakdown FY2021
Total Liabilities: $134.5M
Asset Breakdown
Total Assets: $476.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $80.5M | 16.9% |
| Accounts Receivable | $6.0M | 1.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $11.3M | 2.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $378.9M | 79.5% |
Liabilities Breakdown
Total Liabilities: $134.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.7M | 4.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $127.8M | 95.1% |